What if you could help change melanoma research and outcomes for the better?
In order to save lives, we have to strategically improve melanoma research. Breast cancer did it. Prostate cancer did it. Melanoma can do it now with the opening of a national primary tissue bank. It is the key to the cure. Watch our video to learn more.
The investigational immunotherapeutic IMC-20D7S was safe, well tolerated, and showed signs of modest clinical activity for patients with advanced melanoma, according to results from a... […]
Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first... […]
Melanoma tumors switch to an alternative energy system when they develop resistance to chemotherapy, making that alternative system an attractive target for new treatments, according to researchers... […]
A large study published by the Department of Biostatistics at the University of Oslo in the highly ranked Journal of Clinical Oncology found that using high factor sunscreen compared with low... […]
Find out how you can help.